Webinars

Strategies for Poorly Soluble Drugs

We are delighted to announce details of our upcoming webinar taking place on Tuesday 27th November at 15:00 GMT.
Co-crystallisation is gaining significant interest as an enabling solution for active pharmaceuticals which have poor or limiting bioavailability, and as a mechanism for Intellectual Property (IP) protection.

Read More

Antibody Drug Conjugates

During this webinar we look at Drug Discovery Beyond the Traditional: New Approaches to Biotherapeutics, including next-generation Antibody-Drug Conjugates.

Read More

Solid Forms in Drug Discovery

During this webinar, we look specifically at Solid forms in drug discovery and development, which remains an area of intense interest to the pharmaceutical industry and consequently to the CROs supporting medicinal chemistry projects . Understanding and control of crystalline solid form is fundamental to both efficient large scale synthesis and the creation of stable, consistent and effective drug formulations.

Read More

Sugar Modified Nucleosides and Nucleotides: The Synthesis of Anti-Viral Drugs

In this webinar we cover some of the most important synthetic strategies that allow chemists to make key structural changes to the sugar-portion of nucleosides. The program is focused on the development of experimental nucleoside analogues containing locked nucleic acids for the treatment of HCV and will highlight the problems nucleoside chemists face when working to develop new antiviral drugs.

Read More